Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593359 · ClinicalTrials.gov registry record
Intraocular Pressure During Spine Surgery
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT00593359 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT00593359 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study will compare the effect of two intravenous solutions on eye pressure during spine surgery in the following groups: Group A - Lactated Ringer's replacement for blood loss and placebo eye drops Group B - Lactated Ringer's replacement for blood loss and brimonidine eye drops Group C - Albumin replacement for blood loss and placebo eye drops Group D - Albumin replacement for blood loss and brimonidine eye drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00593359
The ClinicalTrials.gov registry entry for NCT00593359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00593359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00593359 about?
NCT00593359 is a clinical study titled "Intraocular Pressure During Spine Surgery". This study will compare the effect of two intravenous solutions on eye pressure during spine surgery in the following groups: Group A - Lactated Ringer's replacement for blood loss and placebo eye drops Group B - Lactated Ringer's replacement for blood loss and brimonidine eye drops Group C - Alb...
What is the current status of trial NCT00593359?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-12. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00593359?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.